FDA Turns Adverse-Event Reporting Scrutiny On Hospitals

The US agency detailed potential adverse-event reporting violations at 15 hospitals in FDA-483 forms that were posted online by FDA to highlight the need to shift to an active, electronic based device surveillance system.